What is the argument against AHZ splitting into two companies: one that focuses on developing and selling world-class Medtech and the other that focuses on curing cancer and wiping out Herpes?
I find it bizarre that AHZ is doing both: on one hand it makes profits from at least one of its medtech products, and on the other, it feeds the money-sucking biotech-hopeful side of the business.
this could be a case of where 1 + 1 = 1 and a half
split them into two and it could be 1 + 1 = 3
- Forums
- ASX - By Stock
- AVR
- AHZ is 2 companies -why not split into 2?
AHZ is 2 companies -why not split into 2?
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$17.97 |
Change
-0.235(1.29%) |
Mkt cap ! $345.3M |
Open | High | Low | Value | Volume |
$18.09 | $18.09 | $17.88 | $1.182K | 66 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 60 | $17.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.05 | 554 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 60 | 17.880 |
1 | 47 | 17.870 |
1 | 619 | 17.860 |
1 | 37 | 17.650 |
2 | 700 | 17.550 |
Price($) | Vol. | No. |
---|---|---|
18.050 | 554 | 1 |
18.100 | 1000 | 1 |
18.200 | 343 | 2 |
18.300 | 150 | 1 |
18.500 | 43 | 1 |
Last trade - 14.30pm 10/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online